Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Glaukos Corp (NY: GKOS ) 113.02 +1.36 (+1.22%) Official Closing Price Updated: 7:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Glaukos Corp < Previous 1 2 3 4 5 6 7 Next > 55 Biggest Movers From Yesterday July 15, 2021 Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance with Nasdaq's listing standards on July 12 by... Via Benzinga Mid-Afternoon Market Update: Dow Gains 50 Points; Imara Shares Plunge July 14, 2021 Toward the end of trading Wednesday, the Dow traded up 0.15% to 34,942.77 while the NASDAQ rose 0.07% to 14,687.21. The S&P also rose, gaining 0.26% to 4,380.58. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities Glaukos plunges after CMS suggests slashing iStent reimbursement July 14, 2021 William Blair downgraded Glaukos following the Via Talk Markets Glaukos's Earnings: A Preview May 04, 2021 Glaukos (NYSE:GKOS) announces its next round of earnings this Wednesday, May 05. Here is Benzinga's look at Glaukos's Q1 earnings report. Net Income, Earnings, And Earnings Per... Via Benzinga Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety Why Glaukos's Stock is Up During Today's Session April 08, 2021 Glaukos's Stock Price And Volume Action Glaukos (NYSE:GKOS) is curre... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session July 14, 2021 Gainers AcelRx Pharmaceuticals (NASDAQ:ACRX Via Benzinga Mid-Day Market Update: Aspen Group Drops Following Q4 Results; Datasea Shares Surge July 14, 2021 Midway through trading Wednesday, the Dow traded up 0.05% to 34,907.35 while the NASDAQ rose 0.48% to 14,747.61. The S&P also rose, gaining 0.24% to 4,379.85. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities 34 Stocks Moving In Wednesday's Mid-Day Session July 14, 2021 Gainers Datasea Inc. (NASDAQ: DTSS) climbed 85% to $5.42. Datasea’s subsidiary Shuhai Zhangxun Information Technology Co., Ltd inked six purchase and distribution... Via Benzinga Why Glaukos Stock Is Tanking Today July 14, 2021 Proposed rates from CMS for fiscal 2022 weren't what investors expected. Via The Motley Fool Mid-Morning Market Update: Markets Open Higher; Citigroup Earnings Beat Expectations July 14, 2021 Following the market opening Wednesday, the Dow traded up 0.26% to 34,979.05 while the NASDAQ rose 0.40% to 14,736.66. The S&P also rose, gaining 0.30% to 4,382.38. The U.S.... Via Benzinga Topics Earnings Stocks Exposures Financial US Equities Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021 July 14, 2021 Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE: Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session July 14, 2021 Gainers Qualigen Therapeutics (NASDAQ:QLGN) stock moved upwards by 8.98% to $1.94 during Wednesday's pre-market session. The market value of their outstanding shares... Via Benzinga William Blair Downgrades Glaukos After Disappointing CMS Rate; Shares Drop July 14, 2021 Centers for Medicare and Medicaid Services (CMS) issued its fiscal 2022 proposed physician fee schedule, which included two combined Category I cataract plus stent procedure... Via Benzinga Glaukos Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Physician Fee Schedule July 14, 2021 From Glaukos Corporation Via Business Wire Glaukos Stock Sees Its Relative Strength Rating Improve To Key Above-80 Level July 01, 2021 Glaukos stock had its Relative Strength (RS) Rating upgraded from 78 to 81 Thursday. Is Glaukos on your watchlist? Via Investor's Business Daily Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. NDA Phase 3 Clinical Trials for iDose® TR June 10, 2021 From Glaukos Corporation Via Business Wire Glaukos Announces Australia’s TGA Regulatory Approval for PRESERFLO™ MicroShunt June 08, 2021 From Glaukos Via Business Wire Glaukos Announces Participation in the William Blair 41st Annual Growth Stock Conference May 19, 2021 From Glaukos Corporation Via Business Wire Glaukos Expands its PRESERFLO™ MicroShunt Relationship with Santen via New License Agreement May 18, 2021 From Glaukos Corporation Via Business Wire Glaukos Corp (GKOS) Q1 2021 Earnings Call Transcript May 05, 2021 GKOS earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Glaukos Corporation Announces First Quarter 2021 Financial Results May 05, 2021 From Glaukos Corporation Via Business Wire Glaukos Announces the Release of its 2020 Sustainability Report April 27, 2021 From Glaukos Corporation Via Business Wire Glaukos Announces Global Licensing Agreement Amendment with Intratus, Inc. to Include the Treatment of Presbyopia April 22, 2021 From Glaukos Corporation Via Business Wire The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues May 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... Via Benzinga The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs April 22, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,... Via Benzinga Glaukos Corporation to Release First Quarter 2021 Financial Results after Market Close on May 5 April 14, 2021 From Glaukos Corporation Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2021 April 08, 2021 Upgrades According to Oppenheimer, the prior rating for Glaukos Corp (NYSE:GKOS) was changed from Perform to Outperform. Glaukos earned $0.02 in the fourth quarter,... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.